AT503461T - Pharmaceutical compositions for the treatment of asthma - Google Patents

Pharmaceutical compositions for the treatment of asthma

Info

Publication number
AT503461T
AT503461T AT09006110T AT09006110T AT503461T AT 503461 T AT503461 T AT 503461T AT 09006110 T AT09006110 T AT 09006110T AT 09006110 T AT09006110 T AT 09006110T AT 503461 T AT503461 T AT 503461T
Authority
AT
Austria
Prior art keywords
asthma
treatment
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
AT09006110T
Other languages
German (de)
Inventor
Joel A Sequeira
Stefan A Sharpe
John L Hart
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US31538601P priority Critical
Application filed by Schering Corp filed Critical Schering Corp
Publication of AT503461T publication Critical patent/AT503461T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23224164&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT503461(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
AT09006110T 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma AT503461T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US31538601P true 2001-08-28 2001-08-28

Publications (1)

Publication Number Publication Date
AT503461T true AT503461T (en) 2011-04-15

Family

ID=23224164

Family Applications (2)

Application Number Title Priority Date Filing Date
AT09006110T AT503461T (en) 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma
AT02753549T AT430555T (en) 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02753549T AT430555T (en) 2001-08-28 2002-08-27 Pharmaceutical compositions for the treatment of asthma

Country Status (27)

Country Link
US (3) US20030114428A1 (en)
EP (3) EP2319494B1 (en)
JP (3) JP2005502675A (en)
KR (1) KR100970531B1 (en)
CN (2) CN101856362A (en)
AR (1) AR036358A1 (en)
AT (2) AT503461T (en)
AU (1) AU2002313828B2 (en)
BR (1) BR0212089A (en)
CA (1) CA2457926A1 (en)
CO (1) CO5560551A2 (en)
CY (2) CY1109212T1 (en)
DE (2) DE60232251D1 (en)
DK (2) DK1420759T3 (en)
ES (3) ES2389480T3 (en)
HK (3) HK1060972A1 (en)
HU (1) HU0401514A3 (en)
MX (1) MXPA04001875A (en)
NO (1) NO20041277L (en)
NZ (1) NZ530987A (en)
PE (1) PE03902003A1 (en)
PL (1) PL209640B1 (en)
PT (2) PT2092935E (en)
SI (2) SI2092935T1 (en)
TW (1) TWI324934B (en)
WO (1) WO2003020253A2 (en)
ZA (1) ZA200401419B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
HU229798B1 (en) * 2001-03-30 2014-07-28 Jagotec Ag Medical aerosol compositions and process for their preparation
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
ES2388537T3 (en) * 2002-08-23 2012-10-16 Merck Sharp & Dohme Corp. metered dose inhaler containing a suspension formulation of aerosol
EP1785156B1 (en) * 2002-08-23 2012-06-27 Schering Corporation Metered dose inhaler containing an aerosol suspension formulation
EP1542904B1 (en) * 2002-08-27 2008-01-16 Schering Corporation Process for producing metered dose inhaler formulations
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
WO2005041931A2 (en) * 2003-10-20 2005-05-12 Schering Corporation Pharmaceutical aerosol compositions
EP1925293A3 (en) * 2003-10-20 2010-01-13 Schering Corporation Pharmaceutical aerosol compositions
EP1711164B1 (en) * 2004-01-21 2010-03-24 Schering Corporation Method of treating acute rhinosinusitis
US20110053999A1 (en) * 2004-03-03 2011-03-03 Daley Thomas E 4-methylpyrazole formulations for inhibiting ethanol intolerance
AT404186T (en) * 2004-10-12 2008-08-15 Generics Uk Ltd A process for the preparation of suspension aerosol formulations in which the particles are formed by präzipition in an aerosol container
MX2007012084A (en) 2005-03-30 2007-11-21 Schering Corp Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist.
US20070203104A1 (en) * 2006-02-09 2007-08-30 Chaudhry Saeed M Pharmaceutical Formulations
US20080253970A1 (en) * 2007-02-09 2008-10-16 Schering Corporation Stable Pharmaceutical Drug Products
AU2007346134A1 (en) * 2007-02-09 2008-08-14 Merck Sharp & Dohme Corp. Stable pharmaceutical drug aerosols
GB0714239D0 (en) * 2007-07-20 2007-08-29 Glaxo Group Ltd Method
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
MX2010007569A (en) * 2008-01-10 2011-03-21 Schering Corp Star Inhalation drug products, systems and uses.
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
JP5670421B2 (en) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Component surface coating method
EP3508239A1 (en) 2009-05-18 2019-07-10 Boehringer Ingelheim International GmbH Adapter, inhalant apparatus and atomizer
PL2435025T3 (en) * 2009-05-29 2017-08-31 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
CN104225735B (en) 2009-11-25 2018-12-07 贝林格尔.英格海姆国际有限公司 sprayer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011064163A1 (en) 2009-11-25 2011-06-03 Boehringer Ingelheim International Gmbh Nebulizer
ES2487634T3 (en) * 2009-12-07 2014-08-22 Raptor Therapeutics Inc. 4-methylpyrazole formulations
WO2011101828A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sidium fusidate and incorporating a biopolymer and betamethasone, and a process to make it
WO2011101830A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and clobetasone, and a process to make it
EP2585151B1 (en) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Nebulizer
WO2012017368A1 (en) 2010-08-02 2012-02-09 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, beclomethasone dipropionate and a process to make it
WO2012049543A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it
EP2694220A1 (en) 2011-04-01 2014-02-12 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
DK2765994T3 (en) * 2011-10-11 2019-03-04 Chiesi Farm Spa Crystalline microparticles of a beta agonist coated with a fatty acid
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
EP2835146A1 (en) 2013-08-09 2015-02-11 Boehringer Ingelheim International GmbH Nebulizer with blocking mechanism
JP2016527041A (en) 2013-08-09 2016-09-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
KR20170016832A (en) 2014-05-07 2017-02-14 베링거 인겔하임 인터내셔날 게엠베하 Container, nebulizer and use
EA032832B1 (en) 2014-05-07 2019-07-31 Бёрингер Ингельхайм Интернациональ Гмбх Nebulizer
GB2545025A (en) * 2015-12-04 2017-06-07 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2017156287A1 (en) * 2016-03-09 2017-09-14 Proveris Scientific Corporation Methods for measuring dose content uniformity performance of inhaler and nasal devices
CN106619658A (en) * 2016-12-28 2017-05-10 四川普锐特医药科技有限责任公司 Medical aerosol preparation and quantitatively-inhaled aerosol

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
CA2111002C (en) * 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
US6250300B1 (en) * 1992-12-11 2001-06-26 Ab Astra System for dispensing pharmaceutically active compounds
BR9510510A (en) * 1994-12-22 1998-07-07 Astra Ab Pharmaceutical aerosol formulation use thereof and processes for the manufacture thereof for treating a patient in need of therapy
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
TR199900379T2 (en) * 1996-08-29 1999-05-21 Schering Corporation mometasone furoate aerosol formulations contain chlorofluorocarbon.
SE9700135D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) * 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
US6495167B2 (en) * 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
TW533865U (en) * 1997-06-10 2003-05-21 Glaxo Group Ltd Dispenser for dispensing medicament and actuation indicating device
GB2359749B (en) * 1998-11-26 2004-05-05 Britannia Pharmaceuticals Ltd Anti-asthmatic combinations comprising surface active phospholipids
AR022695A1 (en) * 1999-01-28 2002-09-04 Schering Corp CARRIER AND METHOD FOR solid particulate provide control of particulate size distribution FOR PARTICLE AND CONVERTIBLE amorphous content during preparation
GB9904919D0 (en) * 1999-03-03 1999-04-28 Novartis Ag Organic compounds
SE9900833D0 (en) * 1999-03-09 1999-03-09 Astra Ab Novel combination
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
DE60103504T2 (en) * 2000-01-20 2005-06-09 Basilea Pharmaceutica Ag Nasally administrable antifungal cyclic peptide compositions
GB0009612D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic formulations
AU7811501A (en) * 2000-08-04 2002-02-18 Longwood Pharmaceutical Res In Formulations of mometasone and a bronchodilator for pulmonary administration
TW200301698A (en) * 2001-12-21 2003-07-16 Squibb Bristol Myers Co Acridone inhibitors of IMPDH enzyme

Also Published As

Publication number Publication date
CN1649568B (en) 2010-10-27
CA2457926A1 (en) 2003-03-13
ZA200401419B (en) 2005-01-26
MXPA04001875A (en) 2004-06-15
NO20041277L (en) 2004-03-26
AU2002313828B2 (en) 2005-09-08
TWI324934B (en) 2010-05-21
HK1060972A1 (en) 2009-07-17
CN1649568A (en) 2005-08-03
CY1109212T1 (en) 2014-07-02
NZ530987A (en) 2006-08-31
DE60232251D1 (en) 2009-06-18
CO5560551A2 (en) 2005-09-30
US20030114428A1 (en) 2003-06-19
WO2003020253A3 (en) 2003-05-22
HU0401514A2 (en) 2004-12-28
DK1420759T3 (en) 2009-08-03
AR036358A1 (en) 2004-09-01
PL368897A1 (en) 2005-04-04
JP2005502675A (en) 2005-01-27
JP2010138184A (en) 2010-06-24
PE03902003A1 (en) 2003-04-24
JP5170789B2 (en) 2013-03-27
US20050147565A1 (en) 2005-07-07
ES2361805T3 (en) 2011-06-22
WO2003020253A2 (en) 2003-03-13
EP2319494A1 (en) 2011-05-11
BR0212089A (en) 2004-08-03
SI1420759T1 (en) 2009-10-31
CN101856362A (en) 2010-10-13
US20100143269A1 (en) 2010-06-10
EP1420759B1 (en) 2009-05-06
SI2092935T1 (en) 2011-07-29
HU0401514A3 (en) 2012-08-28
HK1128428A1 (en) 2011-06-10
PT2092935E (en) 2011-05-31
EP2319494B1 (en) 2012-06-13
HK1151987A1 (en) 2012-10-12
EP2092935A1 (en) 2009-08-26
ES2389480T3 (en) 2012-10-26
DK2092935T3 (en) 2011-07-18
EP2092935B1 (en) 2011-03-30
AT430555T (en) 2009-05-15
KR100970531B1 (en) 2010-07-16
KR20040031002A (en) 2004-04-09
JP2009185075A (en) 2009-08-20
CY1111726T1 (en) 2015-10-07
ES2325316T3 (en) 2009-09-01
DE60239648D1 (en) 2011-05-12
EP1420759A2 (en) 2004-05-26
PT1420759E (en) 2009-06-30
PL209640B1 (en) 2011-09-30

Similar Documents

Publication Publication Date Title
DE60019722D1 (en) Pharmaceutical compositions for discomfort rundown
DE69931794D1 (en) Therapeutic compositions for treatment of mucus
DE60208794D1 (en) 4'-substituted nucleosides for the treatment of Hepatitis C virus-mediated diseases
DE60121992D1 (en) Composition for administration and coating medical devices
EE200300369A (en) Acylated indanüülamiinid, process for their preparation, and the use of a pharmaceutical formulation
AT551606T (en) Tissue processor for the treatment of histological tissue preparations
NO20041041L (en) Fenetanolaminderivater for treating respiratory diseases
DE60235083D1 (en) Substituted tetracycline compounds for treatment of malaria
AT450269T (en) Pyyä3-36ü peptide for the treatment of metabolic diseases
DE60028358D1 (en) Hmg1 antagonist for treatment of inflammation
DE60110379D1 (en) Plasma device for treatment of tissue surfaces
RU2005104418A (en) Pharmaceutical compositions for the treatment of neurological disorders comprising dextromethorphan and kvinidin
DE69507029T2 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated diseases
DE60114808D1 (en) Surface treatment of medical device-
DE60119906D1 (en) Compositions for increasing the volume of tissue and coating compositions
DE60035378D1 (en) Device for the treatment of intervertebral discs
DE60239425D1 (en) Kalziumatorvastatin pharmaceutical formulation containing
NO20033556D0 (en) pharmaceutical compositions
DE60220909D1 (en) Administration of drugs for the treatment of erectile dysfunction by inhalation
DE60200547D1 (en) Device for the treatment of respiratory affections
DE60112942D1 (en) Compounds for the treatment of disease alzheimerischen
RU2004134560A (en) Methods and compositions for the treatment of pain
DE60231804D1 (en) Use of hepcidin for the manufacture of a medicament for the treatment of iron homeostasis disorders
DE69903543T2 (en) Formulations for the treatment of gastroesophageal reflux
EE05472B1 (en) Fumaarhappeamiidide as medicine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2092935

Country of ref document: EP